Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.27B |
| 2 |
Blackrock
BLK
|
+$1.21B |
| 3 |
PG&E
PCG
|
+$1.17B |
| 4 |
Alibaba
BABA
|
+$1.12B |
| 5 |
T-Mobile US
TMUS
|
+$826M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$1.34B |
| 2 |
Boston Scientific
BSX
|
+$1.26B |
| 3 |
American Express
AXP
|
+$1.23B |
| 4 |
GE Aerospace
GE
|
+$1.1B |
| 5 |
Visa
V
|
+$993M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.88% |
| 2 | Healthcare | 16.37% |
| 3 | Consumer Discretionary | 13.18% |
| 4 | Financials | 11.24% |
| 5 | Communication Services | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
CarMax
KMX
$8.26B
| $29.6M | ﹤0.01% |
330,334
+173,224
| +110% | +$13.6M |
|
|
OSG
1377
Octave Specialty Group
OSG
$222M
| $29.5M | ﹤0.01% |
2,060,260
| – | – |
|
1378
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
| $29.5M | ﹤0.01% |
1,705,482
-881,558
| -34% | -$14.7M |
|
|
ELP
1379
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $29.4M | ﹤0.01% |
6,688,620
-83,810
| -1% | -$371K |
|
1380
Atara Biotherapeutics
ATRA
$76.1M
| $29.3M | ﹤0.01% |
80,463
+53,536
| +199% | +$13.5M |
|
|
CCI.PRA
1381
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $29.3M | ﹤0.01% |
19,689
-14,500
| -42% | -$20.7M |
|
1382
Rush Enterprises Class A
RUSHA
$6.22B
| $29.1M | ﹤0.01% |
1,578,854
-4,500
| -0.3% | -$75K |
|
1383
Dine Brands
DIN
$452M
| $29M | ﹤0.01% |
688,161
+28,500
| +4% | +$1.15M |
|
1384
Enviri
NVRI
$620M
| $29M | ﹤0.01% |
2,144,050
+913,626
| +74% | +$9.18M |
|
|
GWB
1385
DELISTED
Great Western Bancorp, Inc.
GWB
| $28.9M | ﹤0.01% |
2,102,593
-371,414
| -15% | -$5.89M |
|
|
DHR.PRA
1386
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $28.8M | ﹤0.01% |
23,050
-150
| -0.6% | -$177K |
|
1387
Encompass Health
EHC
$12.4B
| $28.8M | ﹤0.01% |
583,844
-488,700
| -46% | -$26.4M |
|
1388
Viasat
VSAT
$11.1B
| $28.5M | ﹤0.01% |
742,973
+388,546
| +110% | +$15.8M |
|
1389
iShares International Developed Real Estate ETF
IFGL
$83.2M
| $28.5M | ﹤0.01% |
1,229,282
-35,645
| -3% | -$810K |
|
1390
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.56B
| $28.5M | ﹤0.01% |
547,600
+245,036
| +81% | +$12.4M |
|
|
PING
1391
DELISTED
Ping Identity Holding Corp.
PING
| $28.5M | ﹤0.01% |
886,814
+579,514
| +189% | +$15.4M |
|
|
VMW
1392
DELISTED
VMware, Inc
VMW
| $28.3M | ﹤0.01% |
183,044
-206,783
| -53% | -$28.4M |
|
|
BSX.PRA
1393
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
| $28.3M | ﹤0.01% |
+270,000
| New | +$28.9M |
|
1394
Dover
DOV
$28.4B
| $28.3M | ﹤0.01% |
293,000
-163,162
| -36% | -$15.1M |
|
1395
Pediatrix Medical
MD
$2.2B
| $28.2M | ﹤0.01% |
1,651,571
+71,290
| +5% | +$1.06M |
|
1396
Schwab US TIPS ETF
SCHP
$16.3B
| $28.2M | ﹤0.01% |
940,704
-1,742,806
| -65% | -$51.6M |
|
|
MAG
1397
DELISTED
MAG Silver
MAG
| $28.2M | ﹤0.01% |
2,000,000
+89,199
| +5% | +$1.03M |
|
1398
Progyny
PGNY
$2.2B
| $28.2M | ﹤0.01% |
1,093,386
+678,054
| +163% | +$15.6M |
|
1399
Heron Therapeutics
HRTX
$92.9M
| $28.2M | ﹤0.01% |
1,917,768
-601,834
| -24% | -$9.89M |
|
|
ALTR
1400
DELISTED
Altair Engineering Inc
ALTR
| $28.1M | ﹤0.01% |
706,121
-123,393
| -15% | -$4.19M |
|
Similar funds
Fidelity Investments's Q2 2020 Portfolio in Review
As of Q2 2020, Fidelity Investments held 4,490 positions worth $909B, up 26% from $722B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Fidelity Investments's Q2 2020 filing shows 334 new, 1,365 increased, 1,743 reduced and 502 closed positions. Its largest new stake was Royalty Pharma: 16,356,491 shares worth $743M. The largest sale was iShares US Treasury Bond ETF, an estimated $1.34B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fidelity Investments's largest Q2 2020 buy was Royalty Pharma: 16,356,491 shares worth $743M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q2 2020, an estimated $2.27B increase.
- Fidelity Investments's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.34B.
- Fidelity Investments fully exited Sprint Corporation in Q2 2020, selling an estimated $225M.
- Fidelity Investments's ten largest holdings make up 28% of its $909B portfolio in Q2 2020.
- Fidelity Investments opened 334 new positions and closed 502 in Q2 2020.
- Fidelity Investments's portfolio value rose 26% quarter-over-quarter to $909B.
Based on Fidelity Investments's 13F filing for Q2 2020, filed 13 Aug 2020.